John Smallridge
Researcher at Reconnect Labs AG
Papers
5 publications
Trials
0 clinical trials
Key Impact
He is a coauthor on several recent psychedelic pharmacology and consciousness studies involving DMT, harmine, psilocybin, and EEG/TMS-EEG methods.
Background & Research
John W. Smallridge appears to be a researcher affiliated with Reconnect Labs AG in Winterthur, Switzerland. He is listed as a coauthor on studies spanning psychedelic drug mechanisms, DMT-harmine pharmacokinetics/pharmacodynamics, mindfulness-retreat research, and altered-states EEG work. Publicly available sources in this search did not clearly surface a more detailed academic bio or a unique faculty position.
Collaboration Network
10 collaborators· click a node to visit their profile
Full network →